Semba Charles Pauling 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Semba Charles Pauling
Director
Transactions
- Award
Common Stock
2026-01-02$8.42/sh+3,355$28,249→ 47,963 total
Footnotes (1)
- [F1]Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."